Three-dimensional Changes in Free Gingival Grafts Around Dental Implants
ConditionInsufficient Keratinized Gingiva
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBiruni University
About this trial
The purpose of this study is to evaluate the stability of the free gingival graft dimensions around dental implants and to compare three-dimensional changes according to smoking status. Its primary goal is to provide an answer to:
Is this grafting procedure stable around dental implants? Are there any differences in tissue stability between smoker and non-smoker patients?
Our study consists of 2 groups:
The first group includes smoker patients who need free gingival grafts around their dental implants (n=16).
The second group includes non-smoker patients who need free gingival grafts around their dental implants (n=16).
Clinical measurements will be recorded at the baseline, 1st month, 3rd month, and 6th month of the study. An intraoral digital scanner will be used to measure the dimension changes of the graft at the baseline, after the surgery, 1st month, 3rd month, and 6th month of the study. Wound healing will be evaluated on postoperative days 10, 1 month, 3 months, and 6 months. Visual Analog Scale will be used to measure postoperative pain, and the number of painkillers taken will be recorded.
Eligibility criteria
Qualifiers
Periodontal and peri-implant tissue health
Good oral hygiene (plaque accumulation <20%)
Either around the functioning implant or in patients scheduled for second-stage surgery following implant surgery <2 mm keratinized gingiva on the vestibular side of the implant
No systemic disease and medication use that may affect soft tissue healing.
Disqualifiers
Systemic disease that is a contraindication to the surgical procedure,
Uncontrolled diabetes (HbA1c > 7),
Being pregnant or breastfeeding,
Autoimmune and/or inflammatory diseases of the oral cavity,
Trial design
Treatments tested in this trial
- Free gingival graft
Treatment groups
32 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov